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Abstract
Background: The most deadly form of cancer is not lung or colon, breast or prostate; it is any cancer that has become
metastatic. Mortality due to metastatic melanoma, one of the most aggressive and deadly cancers, has increased steadily
over the last several decades. Unfortunately, the arsenal of chemotherapeutic agents available today is most often
unsuccessful at extending and improving the life expectancy of afflicted individuals. We sought to identify an effective and
nontoxic agent against metastatic melanoma.
Methodology/Principal Findings: WechosetostudyCloudmanS-91 mousemelanomacells(sub-clone M3,CCL53.1)because
these cells are highly aggressive and metastatic, representing one of the deadliest types of cancer. Melanoma cells also had an
experimental advantage becausetheir morphology, whichiseasilymonitored,relates tothephysiologyof metastatic cells and
normal melanocytes. We chose to test methyl sulfone as a chemotherapeutic agent for two reasons. Because of its chemical
structure, we speculated a potential anti-cancer activity by targeting microtubules. Equally important, methyl sulfone has a
well-established safety profile in humans. Surprisingly, we found that malignant melanoma cells exposed to methyl sulfone
demonstrated the loss of phenotypes characteristic of malignant cells, and the reemergence of phenotypes characteristic of
healthy melanocytes. Briefly, over time methyl sulfone induced contact inhibition, loss of ability to migrate through an
extracellular matrix, loss of anchorage-independent growth, proper wound healing followed by contact inhibition, irreversible
senescence followed by arborization with melanosomes in arbors as seen in normal melanocytes.
Conclusions/Significance: Methyl sulfone may have clinical potential as a non-toxic agent effective against metastatic
melanoma. Additionally, methyl sulfone has promise as a tool to explore molecular mechanisms of metastatic
transformation as well as fundamental processes such as cell migration, contact inhibition, wound healing and cellular
senescence.
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Introduction
Undoubtedly, the most serious concern with today’s chemo-
therapeutics is that these agents can be highly effective against
primary tumors, but they are virtually ineffective when the disease
becomes metastatic. Left untreated, most types of cancer cells in
primary tumors will eventually become mobile and invasive to
nearby blood or lymph supplies, and metastatic disease will
develop. At this stage, treatment most often becomes palliative.
A second concern with current chemotherapy is the narrow
differential between doses that kill malignant cells and doses that
are toxic to healthy cells. With some chemotherapeutic agents,
this differential can be as narrow as two-fold. In practice,
clinicians must determine optimal dosage for each patient based
on this fine line between benefit (killing cancer cells) and risk
(severity of toxicity). Within certain groups of patients, chemo-
therapy-induced toxicity can be severe and life threatening. For
example, elderly patients, patients with co-morbid conditions and
patients with metastatic disease may not be able to tolerate the
toxic side effects associated with optimal doses. However, a less
than optimal dose or a longer period of time between treatments
can lead to a poor prognosis. If adverse effects become life
threatening, treatment with the causative agent is postponed or
more likely terminated.
Clearly, an ideal chemotherapeutic drug would be a non-toxic
compound that cures metastatic cancer. To identify compounds
that at least come close to this ideal, we searched for two criteria
based on a yeast model for drug discovery [1]: first, the compound
is non-toxic to healthy cells and, second, the chemical structure of
the compound suggests anti-cancer activity.
PLoS ONE | www.plosone.org 1 August 2010 | Volume 5 | Issue 8 | e11788Methyl sulfone is a naturally occurring small molecule found in
all mammals, including humans [2]. Humans do not synthesize
methyl sulfone. Rather, methyl sulfone is acquired through diet. A
primary source of methyl sulfone for people in the United States is
cow’s milk [3]. Cows acquire methyl sulfone by eating grasses.
One type of grass, the plant genus Equisetum (horsetail), is found
throughout the grasslands of North America and contains high
levels of methyl sulfone. Potential toxicity of methyl sulfone has
been extensively tested [4,5]. For example, because methyl sulfone
is used as a solvent in manufacturing, toxicity studies of methyl
sulfone were performed to determine safety levels for workers who
would be exposed to the compound. These studies concluded that
methyl sulfone is essentially non-toxic to humans.
The chemical structure of methyl sulfone, C2H6SO2, is almost
identical to a known microtubule-binding compound, dimethyl
sulfoxide or DMSO (C2H6SO). Thirty or more years ago, DMSO
(10–15%) was a promising new anti-cancer drug because it
induced polymerization and stabilization of microtubules [6],
which in turn it was believed, would inhibit mitosis and kill
proliferating cancer cells. However, extensive studies of DMSO
showed no anti-cancer properties [7,8]. In fact, DMSO became an
organic solvent for other chemotherapeutic drugs such as Taxol
[9,10].
Nevertheless, we explored the possibility that the small differences
in the chemical structures and properties of DMSO and methyl
sulfone may be sufficient for methyl sulfone to be an effective anti-
cancer drug. We show here that methyl sulfone rendered metastatic
melanoma cells from the Cloudman M3 cell line harmless by
permanently reverting their metastatic phenotypes into what
appeared to be non-malignant phenotypes of healthy melanocytes.
The clinical significance is that methyl sulfone may be a non-toxic
chemotherapeutic drug that is effective against metastatic melanoma.
Materials and Methods
Materials
Methyl sulfone and dimethyl sulfoxide were purchased from
Fluka/Sigma Co., St. Louis, MI. Alexa Fluor 488-conjugated
phalloidin was purchased from Invitrogen, Inc., Eugene, OR.
Cell Culture
Cloudman S-91 mouse melanoma cells (sub-clone M-3, CCL
53.1; American Type Culture Collection, Rockville, MD), referred
to here as Cloudman M3 melanoma cells, were grown in RPMI
supplemented with 7% fetal bovine serum (Invitrogen, Inc).
Cultures were passaged twice a week.
Live Cell Microscopy
Cellswere platedon 35 mmtissueculture dishes at aconcentration
of 10
5 cells/plate, unless stated otherwise, and incubated at 37uC,5%
CO2. Cells were videotaped with a Nikon TE300 inverted
microscope equipped with a 1060.25 NA Plan Achromat objective
lens.Timeseries (10 min) of phase contrastimages were acquired at a
video rate of 1 frame/5s with a Watec-902B CCD video camera
(Watec Corp.,Japan) via the stream acquisition optionof Metamorph
image acquisition and analysis software (Universal Imaging Corp.,
Downington, PA). During recordings, cells were kept at 37uCw i t h
10 mM Hepes, pH 7.4. Time series of cells with and without methyl
sulfone were obtained at 0–120 minutes after adding the compound
and every 24–48 hours for up to eight weeks.
Fixed Cell Microscopy of Actin Filaments
Cells were plated on 35mm tissue culture dishes at a concentration
of 10
5 cells/plate and incubated at 37uC, 5% CO2.A f t e r2 4h o u r s ,
medium was replaced with control medium (RPMI without methyl
sulfone)orRPMIwith200 mMmethylsulfone.Aftermelanomacells
reached confluence, cells were fixed in 4% paraformaldehyde and
actin filaments were stained with phalloidin-Alexa-488. Cells were
imaged with a Perkin Elmer Ultraview RS5 spinning-disk confocal
scanning system mounted on a Nikon TE2000 inverted microscope
with a 6361.4 NA Plan Apo oil immersion objective. (William A.
Mohler, Ph.D., Director, Spinning Disk Microscope Facility,
University of Connecticut Health Center).
Cell Proliferation
Cells (10
5 cells/35 mm plate) were plated in RPMI. After
24 hours, medium was replaced with RPMI containing 0, 50 mM,
100 mM, 200 mM and 600 mM methyl sulfone. At several time
points, cells were released from plates by trypsinization and
counted with a hemocytometer. Apoptosis was assessed with the
Annexin V-FITC Apoptosis Kit (PharMingen; Becton-Dickinson,
San Diego, CA). Images were obtained at the Richard D. Berlin
Center for Cell Analysis and Modeling, University of Connecticut
Health Center, Farmington, CT, with an Axioplan CCD
Microscope equipped with a 4061.3 NA FL objective lens,
equipped with a Photometrics PXL-EEV37 high speed digital
cooled CCD camera via Metamorph image acquisition and
analysis software (Universal Imaging Corp., Downington, PA). All
assays were performed at least three times and in triplicate.
DNA Synthesis
DNA synthesis was assayed by incubating cells with bromode-
oxyuridine (BrdU) followed by fixation and incubation with Alexa
Fluor 488-conjugated monoclonal anti-BrdU antibody as de-
scribed by the manufacturer (Molecular Probes, Eugene, OR).
Images were obtained at the Richard D. Berlin Center for Cell
Analysis and Modeling, University of Connecticut Health Center,
Farmington, CT, with an Axioplan CCD Microscope equipped
with a 4061.3 NA FL objective lens, equipped with a Photo-
metrics PXL-EEV37 high speed digital cooled CCD camera via
Metamorph image acquisition and analysis software (Universal
Imaging Corp., Downington, PA).
Cell Invasion
Invasion assays were performed using Transwell Chambers with
8 mm pores (Corning, Inc., Lowell, MA). Membranes were coated
with extracellular matrix gel (Engelbreth-Holm-Swarm murine
sarcoma, Sigma Co., MI) that was diluted 1:6 with RPMI with and
without 200 mM methyl sulfone. Membranes were placed in
chambers containing RPMI with and without 200 mM methyl
sulfone. Cells (1x10
5 cells) were seeded into upper chambers in
RPMI with and without 200 mM methyl sulfone. After 48 and
72 hours at 37 uC, 5% CO2, the number of cells that migrated
through the ECM was determined using an Axioplan CCD
microscope equipped with a 4061.3 NA FL objective lens and
high speed digital cooled CCD camera via Metamorph image
acquisition and analysis software (Universal Imaging Corp.,
Downington, PA). All assays were performed at least three times
and in triplicate.
Soft Agar Colony Formation
Cells from stock plates (RPMI with no methyl sulfone) were
detached from plates by trypsinization and counted. Cells
(5x10
3 cells) were gently suspended in 37uC RPMI containing
0.66% agar (DNA grade; Difco Bacto Agar; Becton Dickenson
and Company, MD) with and without 200 mM methyl sulfone.
The suspension was placed on solidified 1% agar in RPMI with
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37uC with 5% CO2. After 14 days, cells were stained with crystal
violet. Each 35 mm plate was photographed and colonies were
counted with a dissecting microscope. All visible colonies were
counted. All assays were performed at least three times and in
triplicate.
Cell Wounding
Cells were plated on 35 mm tissue culture dishes in RPMI.
When cultures were confluent, medium was replaced with RPMI
with and without 200 mM methyl sulfone. After 48 hours cells
were wounded with a sterile plastic 1000 ml pipette tip. Cells were
washed twice with medium to remove cell debris and incubated at
37uC, 5% CO2 in RPMI with and without 200 mM methyl
sulfone. Wound edges were photographed and video taped with a
Nikon TE300 inverted microscope equipped with a 1060.25 NA
Plan Achromat objective lens. Time-series (5min) of phase contrast
images were acquired at a video rate of 1 frame/3 s with a Watec-
902B CCD video camera (Watec Corp., Japan) via stream
acquisition option of Metamorph image acquisition and analysis
software (Universal Imaging Corp., Downington, PA). During
recordings, cells were kept at 37uC with 10 mM Hepes, pH 7.4.
Time series and photographs of cells with and without 200 mM
methyl sulfone were obtained every 24 hours for up to 120 hours.
Senescence Assay
Senescence was determined with the Senescence Cells Histochem-
ical Staining Kit (Sigma Co, MI) as described by the manufacturer.
From 10 random fields, total number of cells and number of cells
stained blue with b-galactosidase were counted after photographing
images with a Nikon TE300 inverted microscope equipped with a
1060.25 NA Plan Achromat objective lens and an Olympus IM
microscope with a 20x objective and a Nikon L2 digital camera. All
assays were performed at least three times and in triplicate.
Results
Methyl Sulfone Induced Contact Inhibition in Metastatic
Melanoma Cells
Live cell video microscopy demonstrated that metastatic
melanoma cells in 200 mM methyl sulfone reproduced and
migrated until cells came in touch with neighboring cells. At this
point, cells in methyl sulfone stopped migration and formed a
confluent monolayer of contact inhibited cells (Figure 1Ai, 1Aii;
Movie S1). Consistent with contact inhibition is the presence of
actin filaments localized in small, finger-like protrusions along the
plasma membrane as shown in methyl sulfone-treated cells
(Figure 1Aiii). Live cell microscopy showed that these actin-
filled protrusions were constantly ‘‘tapping’’ neighboring cells
across the small space between contact inhibited cells. In contrast,
melanoma cells cultured in the absence of methyl sulfone (control)
retained an amorphous worm-like shape, and after reaching
confluence, continued to migrate under and over neighboring cells
(Figure 1Bi, 1Bii; Movie S2). In addition, actin filaments in
melanoma cells in the absence of methyl sulfone (control cells)
were not localized to plasma membrane protrusions; instead, actin
filaments displayed a more chaotic appearance throughout the
cytoplasm (Figure 1Biii).
Figure 1. Methyl sulfone induced contact inhibition in metastatic melanoma cells. Melanoma cells (10
5 cells/ml) were plated into RPMI
medium. After 24 hours, medium was replaced with RPMI with and without 200 mM methyl sulfone. (A) Melanoma cells in 200 mM methyl sulfone.
Live cell images were acquired 24 hours after media changes (1Ai; Pre-confluent) and every 24 hours for 4 days (1Aii; Confluent); (1Aiii) fixed cell
microscopy of Alexa Fluor 488-conjugated phalloidin-stained actin filaments in confluent methyl sulfone-cells; Movie S1: confluent methyl sulfone-
treated cells. (B) Melanoma cells without methyl sulfone (Control). Live cell images were acquired 24 hours after media changes (1Bi; Pre-confluent)
and every 24 hours for 4 days (1Bii; Confluent); (1Biii) fixed cell microscopy of Alexa Fluor 488-conjugated phalloidin-stained actin filaments in
confluent control cells; Movie S2: confluent control cells. Scale bars correspond to 40 mm.
doi:10.1371/journal.pone.0011788.g001
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methyl sulfone for 20 hours, approximately 22% of cells at 0–
400 mM methyl sulfone underwent apoptosis (p.0.99) indicating no
statistical difference in the percent of apoptotic melanoma cells
cultured in media with 0–400 mM methyl sulfone. At 600 mM,
methyl sulfone induced apoptosis in 63% of the cells (p,0.05 as
assessed by Chi-Square analysis) demonstrating statistical signifi-
cance. Induction of apoptosis is the outcome most often sought for
identifying effective anti-cancer compounds. However, we decided to
focus our studies on 200 mM methyl sulfone first, because initial data
demonstrated the melanoma cells remained viable at 200 mM and
this gave us the opportunity to decipher the actions of this compound.
Second, surprisingly our initial experiments demonstrated that
200 mM methyl sulfone induced contact inhibition and therefore
might prevent progression of the disease by inducing more normal
phenotypes and fewer metastatic phenotypes in melanoma cells.
Methyl sulfone is structurally related to dimethyl sulfoxide
(DMSO), and is in fact a metabolite of DMSO [5]. To determine
whether DMSO induced a similar morphology as methyl sulfone,
we replaced 200 mM methyl sulfone with an equimolar
concentration of DMSO. Microscopic analysis demonstrated that
DMSO had no apparent effect on the melanoma cells after at least
one week in culture.
We next examined the possibility that methyl sulfone caused a
change in extracellular osmolarity. We compared melanoma cells
in control medium, 200 mM methyl sulfone and 200 mM urea.
We chose urea because it has a chemical structure and dipole
moment that is similar to methyl sulfone. However, urea alone did
not mimic the effects of methyl sulfone. Instead, within
approximately two hours, urea induced more then 95% of the
cells into necrotic cell death. Finally, methyl sulfone (50–
1000 mM) did not alter pH of the medium.
Methyl Sulfone Inhibited Cell Proliferation and DNA
Synthesis in Melanoma Cells
Contact inhibition is associated with G1 cell cycle arrest, also
referred to as a state of quiescence. When cells become quiescent,
cell proliferation and DNA synthesis is significantly reduced. To
determine the effect of methyl sulfone on cell proliferation,
melanoma cells were incubated with methyl sulfone (0–200 mM).
At 24, 48 and 72 hours, cells were counted as described in
methods. As shown in Figure 2A, cell proliferation was
significantly inhibited in the presence of 200 mM methyl sulfone
(p,0.0001).
To compare DNA synthesis in control cells and cells treated
with 200 mM methyl sulfone, we examined incorporation
of bromodeoxyuridine (BrdU) into newly synthesized DNA.
Figure 2B shows data from cells at 72 and 96 hours in the
presence or absence of 200 mM methyl sulfone. At 72 hours, 14%
of control cells were synthesizing DNA while only 0.03% of cells in
200 mM methyl sulfone were synthesizing DNA. At 96 hours,
21% of control cells were synthesizing DNA. In contrast, we found
no evidence of DNA synthesis in cells incubated in methyl sulfone
for 96 hours (p,0.0001).
Methyl Sulfone Inhibited Migration of Melanoma Cells
through an Extracellular Matrix
A classic characteristic of metastatic cells is their ability to
migrate through an extracellular matrix. As reviewed by Sahai
in 2007 [11], metastatic cells utilize at least two types of
mechanisms for migration that are essentially not associated
with mature normal cells: first, expression of matrix metallo-
proteinases breaks down the extracellular matrix allowing
metastatic cancer cells to tunnel through tissue; second,
metastatic cells utilize their amorphous shapes and amoeboid
movements to literally squeeze through small spaces (diameters
of approximately 5 mm). Clinically, migration away from the
primary tumor relates to invasion of metastatic cells into
surrounding and then distal tissues. We determined whether
methyl sulfone altered this ability in melanoma cells. In the
absence of methyl sulfone, more than 200 cells migrated
through the matrix. In contrast, none of the cells treated with
200 mM methyl sulfone migrated through the matrix
(Figure 3A;p ,0.0001).
Figure 2. Effect of methyl sulfone on cell proliferation and DNA synthesis. (A) Cell Proliferation: metastatic melanoma cells were incubated
with 0, 50 mM, 100 mM and 200 mM methyl sulfone for up to 72 hours. At each time point, cells were trypsinized from plates and counted. (B) DNA
Synthesis: melanoma cells were incubated with and without 200 mM methyl sulfone for up to 96 hours. DNA synthesis was measured by
incorporation of bromodeoxyuridine (BrdU) followed by fixation and incubation with Alexa Fluor 488-conjugated monoclonal anti-BrdU antibody.
Data presented in (A) and (B) are means +/2 SEM. Asterisks indicate significance between groups (p value=0.0001). Data shown in Figure 2A was
initially analyzed using a two-way analysis of variance, which revealed a significant effect of both dose and time of treatment. Subsequently these
data were analyzed by a one-way analysis of variance followed by a Dunnett’s post hoc test to detected differences between different doses and
times of exposure. Data in Figure 2B was assessed by Chi-Square analysis at both the 72 and 96 hour time points.
doi:10.1371/journal.pone.0011788.g002
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Presence of Methyl Sulfone
Malignant cells do not require attachment or anchorage to a
substratum for growth; instead cancer cells will proliferate and
form colonies when seeded onto culture plates containing soft
agar. This anchorage-independence is another classic character-
istic of melanoma cells. In contrast, normal cells will not proliferate
and therefore will not form colonies on soft agar. We tested
whether methyl sulfone affected anchorage-independent growth of
melanoma cells using the soft agar assay. As shown in Figure 3B,
no colonies formed when melanoma cells were incubated with 200
mM methyl sulfone while more than 300 colonies formed in the
absence of methyl sulfone (p,0.0001).
Wound Healing Proceeded Normally in the Presence of
Methyl Sulfone
Wound healing is a complicated process in which contact
inhibited cells juxtaposed to a wound site must detach from a
substratum, migrate into the wounded area and then become
contact inhibited once the wound is covered. We tested
whether melanoma cells treated with 200 mM methyl sulfone
would function properly in the process of wound healing.
Melanoma cells in the presence and absence of 200 mM
methyl sulfone were grown to confluence. Scraping a layer of
confluent cells with a sterile plastic pipette tip formed a wound.
Using live cell microscopy we monitored migration of cells into
wounds. Melanoma cells treated with 200 mM methyl sulfone
migrated into the wound area. When the wound was covered,
cells treated with 200 mM methyl sulfone stopped migrating
and once again became a confluent monolayer of contact
inhibited cells (Figure 4). In control samples, cells migrated
into the wound area, but did not stop migrating once the
wound site was covered, forming a tumor-like mass at the
wound site.
Over Time Methyl Sulfone Induced Senescence in
Melanoma Cells
During the first two weeks of incubating melanoma cells in 200
mM methyl sulfone, replacement of the methyl sulfone medium
with drug-free medium resulted in the reappearance of metastatic
phenotypes (Figure 5A). In other words, within 24 hours of
incubation in drug-free medium, cells lost contact inhibition and
began proliferating and migrating. At this point we replaced the
drug-free medium with medium containing 200 mM methyl
sulfone. Once again, the cells became contact inhibited. This
cycle of reversal stopped when the cells were incubated in 200
mM methyl sulfone for more than two weeks. As shown in
Figure 5B, after three weeks in the presence of methyl sulfone,
greater than 99% of the melanoma cells became senescent as
judged by b-galactosidase activity which turns senescent cells blue
[12,13]. In contrast, less than 0.1% of control cells were
senescent.
Senescence indicates that cells can never re-enter the cell cycle.
To determine whether the increase in b-galactosidase activity truly
indicated senescence, we replaced medium containing 200 mM
methyl sulfone with drug-free medium on cells that the b-
galactosidase assay indicated were senescent. At one, two and
three weeks after replacing methyl sulfone medium with drug-free
medium, we found that the cells remained senescent (Figure 5C).
As a further test, we detached methyl sulfone-induced senescent
cells from the culture dish by trypsinization and replated the cells
in medium without methyl sulfone. Within 24 hours of replating,
methyl sulfone-primed cells reattached to tissue culture plates in
medium without methyl sulfone, and became contact inhibited; in
contrast, control cells replated into medium without methyl
sulfone displayed no contact inhibition (Figure 5D). Finally,
methyl sulfone-treated cells that were replated into medium
without methyl sulfone again displayed b-galactosidase activity
(Figure 5E).
Figure 3. Effect of methyl sulfone on migration of metastatic melanoma cells through an extracellular matrix (ECM) and on
anchorage-independent growth. (A) Migration through ECM: metastatic melanoma cells in the absence of methyl sulfone migrated through
the extracellular matrix as expected. In contrast, melanoma cells in 200 mM methyl sulfone did not migrate through the ECM. (B) Anchorage-
independent Growth: in the absence of methyl sulfone, melanoma cells were able to grow and form colonies on soft agar. In contrast, no colonies
were apparent when melanoma cells were in the presence of 200 mM methyl sulfone. Data presented in (A) and (B) are means +/2 SEM. Asterisks
indicate significance between groups (p value=0.0001). Data shown in Figure 3A and B were analyzed by a Student’s ‘‘t’’ test. All the statistical
analysis was performed using Prism 5.0 (GraphPad Software, La Jolla, CA) and differences between groups were considered to significant if
p,0.05.
doi:10.1371/journal.pone.0011788.g003
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Melanoma Cells
Mature melanocytes assume a morphology that is similar to
neuronal cells by having a small area of cytoplasm surrounding the
nucleus and long extensions called arbors. The primary function of
melanocytes is to produce melanin and package the melanin in
vesicles called melanosomes. Melanosomes are then transported to
the outermost region of arbors. The arbor tips are phagocytized by
keratinocytes, cells that sit near the skin’s surface, and the newly
acquired melanosomes form an umbrella-like shield around the
nuclei of keratinocytes to protect the DNA of these cells from UV-
induced mutations.
Surprisingly, we found that virtually all of methyl sulfone-
induced senescent melanoma cells took on morphology similar to
mature melanocytes complete with extensive arbors that were
filled with melanosomes (Figure 6). These methyl sulfone-induced
senescent and arborized cells remained viable in culture for at least
three months in the presence or absence of methyl sulfone.
Discussion
Malignant or Metastatic Melanoma
We wanted to test methyl sulfone against the most difficult
cancers to cure. Therefore, we focused our study on metastatic
disease because primary tumors of most cancers are curable while
metastatic cancer is rarely curable. We chose metastatic melanoma
because this is one of the most aggressive and deadly cancers.
Unlike most cancers, melanoma can occur at any age, from
children to the elderly. Additionally, the incidence of melanoma is
rapidly increasing worldwide. Over the last 30 years the incidence
of malignant melanoma increased by 50% among women aged
15–39. While early stage melanoma has a five-year survival rate of
92–97%, late stage or metastatic melanoma has a five-year
survival rate of 15–20% [14].
Melanoma cells have an experimental advantage because their
morphology, which is easily monitored, relates to the physiology of
both metastatic cells and normal melanocytes. For example, after
migrating from the neural crest to the epidermis, the morphology
of melanocytes changes from an amorphous worm-like shape that
is hydrodynamically ideal for migration to an arborized shape
similar to neuronal cells that is optimal for production and transfer
of melanin-containing vesicles, melanosomes, to keratinocytes.
Methyl Sulfone
Methyl sulfone is a small (94.33 mol wt), water-soluble
compound that humans obtain from specific food sources such
as cow’s milk and a variety of vegetables [3]. Interestingly,
vegetables that contain methyl sulfone have been identified as
possible anti-cancer agents, but for compounds other than methyl
sulfone; examples include broccoli, cabbage and Brussels sprouts.
Over the last 50 years, the level of methyl sulfone has decreased in
foods we eat [15]. This decrease is due, at least in part, to an
increase in food processing including pasteurization [3]. It is
premature to speculate on any causal connections between
reduction of methyl sulfone in our environment and the increased
incidence of cancer, but the possibility is interesting. We know that
industrialization has introduced cancer-causing compounds into
our environment. But the opposite, putting an anti-cancer
compound back into our environment, would be progressive.
Methyl Sulfone and Lack of Toxicity
We realize that some people will think that the concentration of
methyl sulfone (200 mM; approximately 2%) used in our studies
seems high and that this concentration may not be obtainable in
human subjects, and if obtainable this concentration would likely
be toxic to patients. In our in vitro studies, we show that Cloudman
M3 melanoma cells in 200 mM methyl sulfone are alive for
Figure 4. Effect of methyl sulfone on wound healing. Melanoma cells were grown to confluence in the presence and absence of 200 mM
methyl sulfone. Scraping a sterile plastic pipette tip through the layer of cells generated a wound. Live cell microscopy was used to monitor wound
healing. Shown are cells photographed at 24 hours after wounding (Early) and three days after wounding (Late). Melanoma cells in the presence and
absence of 200 mM methyl sulfone were able to migrate into the wounds as expected for proper healing. However, once the wound was covered or
healed, cells in 200 mM methyl sulfone stopped migration and once again became contact inhibited. In contrast, melanoma cells in the absence of
methyl sulfone did not properly heal the wound; instead these cells continued to grow and move once the wound was covered. Scale bars
correspond to 40 mm.
doi:10.1371/journal.pone.0011788.g004
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was switched at 24-hour intervals between medium containing no drug (control) and medium with 200 mM methyl sulfone. Shown are three
photographs of the same plate of cells taken at consecutive 24-hour intervals for three days. The left frame shows melanoma cells in control
medium after the first 24-hour interval. The middle frame shows the same plate of cells in 200 mM methyl sulfone after the second 24-hour
interval. The right frame shows the cells back in control medium after the third 24-hour interval. At each change of media, melanoma cells
cycled between no contact inhibition in control medium to contact inhibition in the presence of methyl sulfone. (B) After incubation for 2–3
weeks in the presence of 200 mM methyl sulfone, metastatic melanoma cells became senescent as shown by blue staining of cells due to
increased b-galactosidase activity; control cells continued to migrate and proliferate displaying virtually no blue coloring. (C) To determine if b-
galactosidase activity truly indicated the cell cycle arrest that accompanies senescence, melanoma cells were incubated in medium containing
200 mM methyl sulfone. After three weeks, the methyl sulfone medium was replaced with control medium. Cells were incubated for an
additional two weeks in drug-free medium and then tested for b-galactosidase activity. The cells remained senescent. (D) To further test the
validity of methyl sulfone-induced senescence, melanoma cells were incubated in medium with and without 200 mM methyl sulfone for three
weeks. Cells were then trypsinized and both control cells and methyl sulfone cells were re-plated in medium without methyl sulfone. After
incubation for an additional two weeks, melanoma cells that were initially grown in methyl sulfone once again became contact inhibited while
control cells showed no signs of contact inhibition. (E) Melanoma cells were incubated in 200 mM methyl sulfone. After three weeks, cells were
trypsinized and replated into drug-free medium. After two weeks, the presence of senescent cells was demonstrated by b-galactosidase activity.
Scale bars correspond to 40 mm.
doi:10.1371/journal.pone.0011788.g005
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However, testing of methyl sulfone for toxicity was well in
progress by the 1960’s.
For example, male and female rats were given a daily dose of methyl
sulfone for 90 days at a concentration of approximately 15% at a rate of
1.5 g/kg per day. [5]. This concentration is approximately 750 percent
higher than the concentration we used in our in vitro studies. Based on
the method of administration (gavage), we felt that the stomach and
duodenum would be the most likely areas to find abnormalities.
Animals were checked for clinical signs of toxicity (e.g., body weight;
food consumption) and mortality twice a day. No signs of toxicity were
observed. Laboratory tests were performed before initiation of the
experiment and at week seven. These included blood tests: red blood
cells, white blood cells, platelets, hematocrit, mean corpuscular
hemoglobin, differential leukocyte count, blood coagulation, prothrom-
bin time, liver enzymes, lipid profile, serum protein, albumin, serum
sodium, serum potassium; urinalysis: appearance, volume, specific
gravity, pH, protein, glucose, blood. At 90 days, animals were fasted for
16 hours and then euthanized. A full gross necropsy included weighing
and examining liver, kidneys, adrenals, testicles, spleen, brain, thymus,
heart, mesenteric lymph nodes, submandibular lymph nodes, stomach,
duodenum, pancreas, lungs, pituitary, trachea, esophagus, thyroids,
parathyroids, epididymis, prostate, uterus and ov a r i e s .F i n a l l y ,ab o n e
marrow smear was performed on all animals. Analysis of these data
showed no adverse effects on any of the parameters listed above for
both males and females.
Methyl Sulfone and Contact Inhibition
Contact inhibition, first identified by Kruse and Miedema [16]
and Stoker and Rubin [17], is a complicated process that is still not
well understood [18]. However, it is clear that contact inhibition is
critical for developmental organization of multicellular organisms
and for reorganization of tissue after injury [19]. We show here that
Cloudman M3 melanoma cells in the presence of methyl sulfone
remain contact inhibited until injury or wounding. At this point,
Cloudman M3 melanoma cells in methyl sulfone undergo the
properprocess ofwound healing:directed migrationinto thewound
and becoming contact inhibited once the wound is covered. In
contrast, control cells migrate and cover the wound, but show no
contact inhibition; instead, control cells do not stop once the wound
is healed, producing a tumor-like mass at the wound site.
We show here that in the presence of methyl sulfone, Cloudman
M3 melanoma cells produce a confluent monolayer of flattened
contact inhibited cells. At this early stage of contact inhibition, we
noticed that a small number of spherical-shaped cells appeared to
be tethered to areas of the tissue plate that were not covered with
flattened contact inhibited cells. In fact, we saw no evidence that
these round cells ever spread out or grew over the contact
inhibited cells. Live cell microscopy demonstrated that these
rounded cells were not dead. Nevertheless, we examined these
spherical cells by gently pipeting the cells off of the culture dish
(under these conditions, contact inhibited cells in the confluent
monolayer did not detach) and the spherical cells were plated into
fresh tissue plates in RPMI with 200 mM methyl sulfone.
Interestingly, these once spherical cells now became flattened
and contact inhibited. These data suggest that methyl sulfone-
induced contact inhibition was strong enough to prevent the
spherical cells from growing on top of the original flattened and
contact inhibited cells. We propose that these spherical cells were
‘‘moored’’ to a region of the tissue culture plate that was not
Figure 6. Once senescent, methyl sulfone induced the arborization of metastatic melanoma cells. (A) Examples of arborized melanoma
cells. Cells were photographed and videotaped with a Nikon TE300 inverted microscope equipped with a 1060.25 NA Plan Achromat objective lens.
(B) A highly arborized melanoma cell that was incubated in 200 mM methyl sulfone for four weeks. Cells were photographed using an Olympus IM
microscope with a 20x objective and a Nikon L2 digital camera. Scale bars correspond to 40 mm.
doi:10.1371/journal.pone.0011788.g006
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develop, such as in wounding, the spherical cells will flatten and
become contact inhibited.
Methyl Sulfone and the Instability of Lethal Metastatic
Phenotypes
Studies presented here demonstrate that the fundamental
nature of metastatic melanoma cells can be reversed. This suggests
that methyl sulfone may have the potential to override the effects
of cancer-related changes and induce the reemergence of normal
melanocyte phenotypes. This apparent ability of methyl sulfone to
induce differentiated phenotypes in metastatic Cloudman M3
melanoma cells puts methyl sulfone in a class of chemotherapeutic
agents called ‘‘Differentiation Drugs’’ which includes the vitamin
A-related retinoid family [20,21].
Methyl Sulfone and Senescence
Most normal cells in vivo will become senescent through out the
life time of an individual. For example, in vivo, mature melanocytes
at the epidermis become senescent and remain functional for years
[22,23]. In contrast, Ben-Porath et al. suggested that a defining
property of cancer cells is their inability to become senescent [24].
These authors further suggest that senescence is ‘‘a physiological
response of normal cells that must be overcome in order for tumor
development in vivo or cell immortalization in culture’’. We show
here that methyl sulfone induced approximately 99% of metastatic
melanoma cells into a state of senescence. While methyl sulfone-
induced senescent cells could no longer re-enter the cell cycle,
these cells remained viable in culture for at least three months
while retaining normal phenotypes such as arborization and
production of melanin. Our data suggest that triggering cancer
cells into a senescent state with methyl sulfone may be an effective
approach to subdue the lethal properties of metastatic melanoma.
The concept of induction of senescence rather than apoptosis of
cancer cells as an approach to control cancer was first proposed by
Serrano et al. in 1997 [25]. Over the last decade or so, the concept
of chemotherapy-induced senescence has generated increasing
interest [24,26,27,28,29].
Conclusion
These studies demonstrate that changing the microenvironment
by addition of this molecule changes the life history of metastatic
Cloudman M3 melanoma. The possibility that metastatic
melanoma cells can be ‘‘re-programmed’’ suggests a powerful
tool that permits us to drill down more precisely into mechanisms
that lead to the emergence of cancer pathology.
In conclusion, methyl sulfone may be important, first, as an
effective and non-toxic chemotherapeutic compound to treat
metastatic melanoma cells and perhaps other metastatic cancers.
Additionally, methyl sulfone appears to reprogram metastatic
Cloudman M3 melanoma cells into normal healthy melanocytes.
From these studies, we speculate that methyl sulfone-induced
differentiation may circumvent the development of resistance in
healthy melanocytes. Of equal importance, these studies suggest
that methyl sulfone may be a tool for basic scientists to decipher
fundamental processes whose mechanisms are not well under-
stood: what induces or reverses contact inhibition; what regulates
induction of senescence; what signaling pathways play a role in the
transformation of healthy cells to cancer cells and back to healthy
cells.
Supporting Information
Movie S1 Live cell video of confluent melanoma cells incubated
in RPMI medium with 200 mM methyl sulfone.
Found at: doi:10.1371/journal.pone.0011788.s001 (0.91 MB
MPG)
Movie S2 Live cell video of melanoma cells in RPMI medium in
the absence of methyl sulfone.
Found at: doi:10.1371/journal.pone.0011788.s002 (0.32 MB
MPG)
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